Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2022-04-24 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
拟续聘会计师事务所公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (auditor) for the 2022 fiscal year. It details the auditor's background, independence, audit fees, and the approval process by the board and audit committee. It does not contain any actual audit report, financial statements, or audit results. The document is relatively short (2884 characters) and serves as a formal announcement of the auditor appointment rather than the audit report itself. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit information but is not a full annual report or audit report document. However, since it is an announcement about the auditor appointment and not the audit report itself, it is more appropriate to classify it as Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2022-04-24 Chinese
2021年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for the year 2021" from Sichuan Zitonggong Pharmaceutical Co., Ltd. It details the independent director's attendance at board and shareholder meetings, opinions on various board proposals, committee activities, and efforts to protect investor rights during the 2021 fiscal year. The content focuses on governance, director duties, and compliance with regulatory requirements for independent directors. There are no financial statements or detailed financial performance data presented. The document is a report on board/management activities and director responsibilities rather than a full annual report or audit report. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it is a substantive report, not merely an announcement of a report publication, so it is not RPA or RNS. Confidence is high given the clear focus on director duties and governance.
2022-04-24 Chinese
关于治理专项自查及规范活动相关情况的报告
Governance Information Classification · 95% confidence The document is a detailed report on corporate governance self-inspection and compliance activities by Sichuan Zitonggong Pharmaceutical Co., Ltd. It includes information on company structure, internal systems, board and management composition, decision-making processes, governance constraints, and other compliance-related disclosures. The content focuses on governance practices, board and committee structures, and regulatory compliance rather than financial results or audit opinions. There is no indication that this is an annual report, audit report, earnings release, or any other financial report. The document is not a brief announcement or a proxy solicitation but a comprehensive governance-related report. Therefore, the most appropriate classification is Governance Information (CGR).
2022-04-24 Chinese
第三届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 10th meeting of the 3rd Board of Directors of Sichuan Zitonggong Pharmaceutical Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to various reports and announcements that are to be submitted to the shareholders' meeting. The document primarily concerns board meeting decisions, including management reports, financial reports, audit reports, and other corporate governance matters. It is not the actual reports themselves but the board's resolutions and approvals related to these reports and other corporate actions. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management. The document length (5310 characters) and content confirm it is not a brief announcement or a full report but a board meeting resolution announcement.
2022-04-24 Chinese
出售资产的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement by Sichuan Zitonggong Pharmaceutical Co., Ltd. regarding the sale of idle assets, specifically land use rights and building ownership of an old factory. It includes details about the transaction, asset valuation, board approval, and regulatory compliance. The document explicitly states that the transaction does not constitute a major asset restructuring and is not an affiliated transaction. It also includes the board meeting resolution and an asset appraisal report. The document is an announcement of a specific capital transaction (sale of assets) rather than a full financial report or audit. It does not contain financial statements or earnings data but focuses on the capital/asset sale update. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 3223 characters, which is sufficient for a detailed announcement but not a full report. Hence, the classification is CAP with high confidence.
2022-03-28 Chinese
第三届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's board of directors meeting, including details about meeting attendance, agenda items, and voting results. It includes information about the appointment and removal of a production head and the approval of asset disposal. There is no financial data or comprehensive report content, but rather a summary of board decisions. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related board resolutions.
2022-03-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.